ASX Health Stocks: Control Bionics surges over 50pc after TGA approval of DROVE wheelchair

Perth biotech Botanix to raise $70m following FDA nod for sweat-stopper gel

thewest.com.au - 21/Jun 03:24

Biotech Botanix says it has received firm commitments to raise $70 million from institutional investors just a day after it received US Food and Drug...

ASX Health Stocks: Proteomics to start selling in France; Recce to start clinical trials

stockhead.com.au - 24/Jun 01:59

Proteomics to start selling in France, Recce granted ethical approval for clinical trials, and EMV gets $1.25m grant. ...

ASX Health Stocks: Cleo gains FDA momentum for its ovarian cancer detection tech

stockhead.com.au - 26/Jun 02:42

Positive feedback from the FDA has given Cleo Diagnostics confidence in its US regulatory strategy. Race Oncology confirms RC220's safety. ...

Imricor starts global trial for US FDA approval

stockhead.com.au - 21/Jun 04:48

Imricor’s VISABL-AFL global clinical trial supporting US Food and Drug Administration (FDA) approval has kicked off. ...

ASX wellness stocks offering calm and anxiety relief – Part 2

stockhead.com.au - 23/Jun 20:45

While many Aussies turn to health professionals for mental health and stress, the ASX wellness sector is also looking to ...

FDA grants accelerated approval to epcoritamab-bysp for relapsed or refractory follicular lymphoma

oncologynews.com.au - 01/Jul 16:26

On June 26, 2024, the Food and Drug Administration granted accelerated approval to epcoritamab-bysp, a bispecific CD20-directed CD3 T-cell engager,...

ScoPo’s Powerplays: ASX health stocks rise as M&A activity heats up

stockhead.com.au - 21/Jun 06:37

The S&P/ASX 200 healthcare index is up for the week ending June 21, 2024 boosted by a surge in capital ...

ScoPo’s Powerplays: ASX health stocks hit resistance and fall in first week of FY25

stockhead.com.au - 05:06

Morgans analyst Scott Power said ASX health stocks have fallen for the first week of the 2025 financial year as ...

Raymond Shares Jump Over 5% After NCLT De-Merger Approval

free press journal - 24/Jun 04:24

GSK and Moderna slide on RSV vaccine CDC updates – Proactive Investors USA

canadanewsmedia.ca - 27/Jun 15:21

After GSK PLC (LSE:GSK, NYSE:GSK) shares fell sharply on the back of US authorities restricting doses of respiratory syncytial virus (RSV) vaccine,...

Rubriques :